HPV 16 E6 blocks TNF-mediated apoptosis in mouse fibroblast LM cells

P J Duerksen-Hughes1, J Yang, S B Schwartz

  • 1Department of Biology, Georgia State University, Atlanta, Georgia 30302, USA. biopjd@panther.gsu.edu

Virology
|November 2, 1999
PubMed

Insights

Human papillomavirus type 16 E6 protein confers resistance to tumor necrosis factor (TNF)-induced apoptosis in mouse fibroblast cells. This protection occurs independently of the p53 tumor suppressor, suggesting a novel viral immune evasion strategy.

Area of Science:

  • Virology
  • Immunology
  • Cell Biology

Background:

  • Host-virus interactions involve viral mechanisms to evade host immune responses.
  • Cytokine tumor necrosis factor (TNF)-induced apoptosis is a key host immune strategy targeted by viruses.
  • Mouse fibroblast LM cells are sensitive to TNF-induced cell death.

Purpose of the Study:

  • To investigate the effect of human papillomavirus type 16 (HPV 16) E6 protein on TNF-induced apoptosis in LM cells.
  • To determine the mechanism by which HPV 16 E6 protein confers resistance to TNF.

Main Methods:

  • Expression of wild-type and mutant HPV 16 E6 protein in LM cells.
  • Assessment of TNF-induced apoptosis using cell morphology, cell death ELISA, trypan blue exclusion, and cell proliferation assays.
  • Analysis of p53 levels in TNF-treated cells.

Main Results:

  • Expression of HPV 16 E6 protein rendered LM cells resistant to TNF-induced apoptosis.
  • Resistance to TNF was observed even with a mutant E6 protein unable to degrade p53.
  • p53 levels did not increase in TNF-treated cells prior to apoptosis, indicating a p53-independent mechanism.

Conclusions:

  • The HPV 16 E6 protein protects LM cells from TNF-triggered apoptosis.
  • This protection is likely mediated by a mechanism independent of p53 degradation.

Related Concept Videos